JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 2 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.45B |
| 3 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.34B |
| 4 |
EA
Electronic Arts
EA
|
+$903M |
| 5 |
Automatic Data Processing
ADP
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.63B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.06B |
| 3 |
Meta Platforms (Facebook)
META
|
+$942M |
| 4 |
Nike
NKE
|
+$779M |
| 5 |
Union Pacific
UNP
|
+$543M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.17% |
| 2 | Technology | 12.62% |
| 3 | Healthcare | 10.37% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXAS
2701
CALL
DELISTED
Exact Sciences
EXAS
| $4.5M | ﹤0.01% |
+57,000
| New | +$3.72M |
|
|
EXAS
2702
PUT
DELISTED
Exact Sciences
EXAS
| $4.5M | ﹤0.01% |
+57,000
| New | +$3.72M |
|
|
HBI
2703
DELISTED
Hanesbrands
HBI
| $4.5M | ﹤0.01% |
244,029
-24,718
| -9% | -$479K |
|
|
DQ
2704
Daqo New Energy
DQ
$989M
| $4.49M | ﹤0.01% |
860,185
-2,140,270
| -71% | -$15M |
|
2705
Fresenius Medical Care
FMS
$12.6B
| $4.48M | ﹤0.01% |
87,216
+2,854
| +3% | +$143K |
|
|
OCLR
2706
PUT
DELISTED
Oclaro Inc.
OCLR
| $4.47M | ﹤0.01% |
+500,000
| New | +$4.53M |
|
2707
PUT
Match Group
MTCH
$8.69B
| $4.46M | ﹤0.01% |
+77,100
| New | +$3.61M |
|
2708
iShares Global Energy ETF
IXC
$2.78B
| $4.46M | ﹤0.01% |
118,323
+12,540
| +12% | +$464K |
|
|
VRTV
2709
DELISTED
VERITIV CORPORATION
VRTV
| $4.45M | ﹤0.01% |
122,111
+122
| +0.1% | +$5.23K |
|
2710
Star Bulk Carriers
SBLK
$3.23B
| $4.43M | ﹤0.01% |
306,852
+42,693
| +16% | +$553K |
|
2711
ROBO Global Robotics & Automation Index ETF
ROBO
$2.12B
| $4.42M | ﹤0.01% |
105,711
+6,327
| +6% | +$260K |
|
2712
Team
TISI
$101M
| $4.42M | ﹤0.01% |
19,662
-21,329
| -52% | -$4.83M |
|
2713
iShares US Energy ETF
IYE
$1.83B
| $4.41M | ﹤0.01% |
105,189
-1,464
| -1% | -$60.6K |
|
|
SYRS
2714
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $4.41M | ﹤0.01% |
36,996
+829
| +2% | +$96.2K |
|
|
EGRX
2715
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $4.4M | ﹤0.01% |
63,504
+29,215
| +85% | +$2.21M |
|
2716
Hurco Companies Inc
HURC
$144M
| $4.4M | ﹤0.01% |
97,559
-536
| -0.5% | -$23.5K |
|
2717
iShares MSCI Indonesia ETF
EIDO
$489M
| $4.4M | ﹤0.01% |
191,433
-370,534
| -66% | -$8.61M |
|
2718
PUT
Howmet Aerospace
HWM
$115B
| $4.39M | ﹤0.01% |
260,278
-417,802
| -62% | -$6.65M |
|
|
TPC
2719
Tutor Perini Cor
TPC
$5.1B
| $4.39M | ﹤0.01% |
233,649
+1,815
| +0.8% | +$35.2K |
|
|
SIR
2720
DELISTED
SELECT INCOME REIT
SIR
| $4.39M | ﹤0.01% |
455,387
-55,728
| -11% | -$524K |
|
2721
CALL
Western Digital
WDC
$172B
| $4.39M | ﹤0.01% |
99,225
| – | – |
|
2722
PUT
Weibo
WB
$1.87B
| $4.39M | ﹤0.01% |
60,000
| – | – |
|
|
BNY
2723
CALL
Bank of New York Mellon
BNY
$110B
| $4.38M | ﹤0.01% |
86,000
| – | – |
|
2724
Steven Madden
SHOO
$3.44B
| $4.38M | ﹤0.01% |
124,067
-210,675
| -63% | -$7.82M |
|
2725
Atkore
ATKR
$3.17B
| $4.37M | ﹤0.01% |
164,640
-17,762
| -10% | -$444K |
|
Similar funds
JP Morgan Chase's Q3 2018 Portfolio in Review
As of Q3 2018, JP Morgan Chase held 6,019 positions worth $522B, up 7.4% from $486B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q3 2018 filing shows 449 new, 2,597 increased, 2,100 reduced and 313 closed positions. Its largest new stake was JPMorgan BetaBuilders Canada ETF: 29,437,708 shares worth $1.45B. The largest sale was Broadcom, an estimated $1.63B.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q3 2018 buy was JPMorgan BetaBuilders Canada ETF: 29,437,708 shares worth $1.45B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Japan ETF in Q3 2018, an estimated $1.83B increase.
- JP Morgan Chase's biggest Q3 2018 reduction was Broadcom, cutting an estimated $1.63B.
- JP Morgan Chase fully exited Cavium, Inc. in Q3 2018, selling an estimated $316M.
- JP Morgan Chase's ten largest holdings make up 18% of its $522B portfolio in Q3 2018.
- JP Morgan Chase opened 449 new positions and closed 313 in Q3 2018.
- JP Morgan Chase's portfolio value rose 7.4% quarter-over-quarter to $522B.
Based on JP Morgan Chase's 13F filing for Q3 2018, filed 7 Nov 2018.